litlas
Log inCreate account

Philip S. Bernard

Active 1994–2020

37
Papers
18,314
Citations
33
h-index
37
i10-index

Citations

Citations per year for Philip S. Bernard1990: 1 citations1994: 5 citations1995: 15 citations1996: 15 citations1997: 33 citations1998: 20 citations1999: 22 citations2000: 24 citations2001: 31 citations2002: 23 citations2003: 31 citations2004: 39 citations2005: 35 citations2006: 36 citations2007: 80 citations2008: 106 citations2009: 138 citations2010: 212 citations2011: 248 citations2012: 264 citations2013: 322 citations2014: 294 citations2015: 301 citations2016: 284 citations2017: 249 citations2018: 263 citations2019: 671 citations2020: 603 citations2021: 556 citations2022: 376 citations2023: 309 citations2024: 405 citations2025: 211 citations2026: 19 citations1991–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,413 citing papers, 30.6% of this breakdownChina: 708 citing papers, 9% of this breakdownUnited Kingdom: 525 citing papers, 6.6% of this breakdownCanada: 386 citing papers, 4.9% of this breakdownItaly: 350 citing papers, 4.4% of this breakdownGermany: 312 citing papers, 3.9% of this breakdownSpain: 278 citing papers, 3.5% of this breakdownFrance: 277 citing papers, 3.5% of this breakdownAustralia: 220 citing papers, 2.8% of this breakdownNetherlands: 180 citing papers, 2.3% of this breakdownSweden: 166 citing papers, 2.1% of this breakdownSouth Korea: 164 citing papers, 2.1% of this breakdown
0%30.6%Other 24.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology56.3%
  • Medicine31.8%
  • Computer Science3%
  • Nursing2.4%
  • Immunology and Microbiology1.6%
  • Agricultural and Biological Sciences1.1%
  • Other3.8%

Topics

  • Breast Cancer Treatment Studies8.2%
  • Cancer Cells and Metastasis5.4%
  • Cancer Genomics and Diagnostics4.8%
  • Gene expression and cancer classification4.3%
  • HER2/EGFR in Cancer Research4.3%
  • Bioinformatics and Genomic Networks3.3%
  • Other69.7%

Coauthors

All papers

Open in search
  1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Authors: Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi L. Vickery, Sherri R. Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard - Journal of Clinical Oncology 2009 cited by 4,887

  2. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    Authors: Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen - JNCI Journal of the National Cancer Institute 2009 cited by 2,220

  3. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

    Authors: Yoko S. DeRose, Guoying Wang, Yi‐Chun Lin, Philip S. Bernard, Saundra S. Buys, Mark Ebbert, Rachel E. Factor, Cindy Matsen, Brett Milash, Edward William Nelson, Leigh Neumayer, R. Lor Randall, Inge J. Stijleman, Bryan E. Welm, Alana L. Welm - Nature Medicine 2011 cited by 1,015

  4. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

    Authors: Brett Wallden, James J. Storhoff, Torsten O. Nielsen, Naeem Dowidar, Carl Schaper, Sean Ferree, Shuzhen Liu, Samuel Leung, Gary Geiss, Jacqueline Snider, Tammi L. Vickery, Sherri R. Davies, Elaine R. Mardis, Michael Gnant, Ivana Šestak, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard, Joel S. Parker - BMC Medical Genomics 2015 cited by 560

  5. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

    Authors: Torsten O. Nielsen, Joel S. Parker, Samuel Leung, D. Voduc, Mark Ebbert, Tammi L. Vickery, Sherri R. Davies, Jacqueline Snider, Inge J. Stijleman, Jerry P. Reed, Maggie C.U. Cheang, Elaine R. Mardis, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis - Clinical Cancer Research 2010 cited by 824

  6. TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

    Authors: Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom, Erica L. Mayer, Francisco J. Esteva, X. Cynthia, Minetta C. Liu, Anna Maria Storniolo, Mothaffar F. Rimawi, Andres Forero‐Torres, Antonio C. Wolff, Timothy J. Hobday, Anastasia Ivanova, Wing-Keung Chiu, Madlyn Ferraro, Emily Burrows, Philip S. Bernard, Katherine A. Hoadley, Charles M. Perou, Eric P. Winer - Journal of Clinical Oncology 2012 cited by 493

  7. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

    Authors: Jason I. Herschkowitz, Karl Simin, Victor Weigman, Igor Mikaelian, Jerry Usary, Zhiyuan Hu, Karen Rasmussen, Laundette P. Jones, Shahin Assefnia, Subhashini Chandrasekharan, Michael G. Backlund, Yuzhi Yin, Andrey Khramtsov, Roy Bastein, John Quackenbush, Robert I. Glazer, Powel H. Brown, Jeffrey E. Green, Levy Kopelovich, Priscilla A. Furth, Juan Palazzo, Olufunmilayo I. Olopade, Philip S. Bernard, Gary A. Churchill, Terry Van Dyke, Charles M. Perou - Genome biology 2007 cited by 1,265

  8. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Authors: Aleix Prat, Maggie C.U. Cheang, Miguel Martín, Joel S. Parker, Eva Carrasco, Rosalía Caballero, Scott Tyldesley, Karen A. Gelmon, Philip S. Bernard, Torsten O. Nielsen, Charles M. Perou - Journal of Clinical Oncology 2012 cited by 590

  9. Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

    Authors: Maggie C.U. Cheang, Miguel Martín, Torsten O. Nielsen, Aleix Prat, David Voduc, Álvaro Rodríguez-Lescure, Amparo Ruı́z, Stephen Chia, Lois E. Shepherd, Manuel Ruíz‐Borrego, Lourdes Calvo, Emilio Alba, Eva Carrasco, Rosalía Caballero, Dongsheng Tu, Kathleen I. Pritchard, Mark N. Levine, Vivien Bramwell, Joel S. Parker, Philip S. Bernard, Matthew J. Ellis, Charles M. Perou, Angelo Di Leo, Lisa A. Carey - The Oncologist 2015 cited by 198

  10. Size and shape characterization of hydrated and desiccated exosomes

    Authors: Vasiliy S. Chernyshev, Rakesh Rachamadugu, Yen Hsun Tseng, David M. Belnap, Yunlu Jia, Kyle Branch, Anthony Butterfield, Leonard F. Pease, Philip S. Bernard, Mikhail Skliar - Analytical and Bioanalytical Chemistry 2015 cited by 202

  11. Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

    Authors: Matthew D. Wilkerson, Xiaoying Yin, Vonn Walter, Ni Zhao, Christopher R. Cabanski, Michele C. Hayward, C. Ryan Miller, Mark A. Socinski, Alden M. Parsons, Leigh B. Thorne, Benjamin E. Haithcock, Nirmal K. Veeramachaneni, William K. Funkhouser, Scott H. Randell, Philip S. Bernard, Charles M. Perou, D. Neil Hayes - PLoS ONE 2012 cited by 303

  12. PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

    Authors: Roy R. L. Bastien, Álvaro Rodríguez-Lescure, Mark Ebbert, Aleix Prat, Blanca Munárriz, Leslie R. Rowe, Patricia A. Miller, Manuel Ruíz‐Borrego, D.P. Anderson, Bradley W. Lyons, Isabel Álvarez, Tracy Dowell, David Wall, Miguel Ángel Seguí, Lee Barley, Kenneth M. Boucher, Emilio Alba, Lisa M. Pappas, Carole Davis, Ignacio Aranda, Christiane Fauron, Inge J. Stijleman, José Palacios, Antonio Antón, Eva Carrasco, Rosalía Caballero, Matthew J. Ellis, Torsten O. Nielsen, Charles M. Perou, Mark E. Astill, Philip S. Bernard, Miguel Martín - BMC Medical Genomics 2012 cited by 343

  13. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

    Authors: Minetta C. Liu, Brandelyn N. Pitcher, Elaine R. Mardis, Sherri R. Davies, Paula N. Friedman, Jacqueline Snider, Tammi L. Vickery, Jerry P. Reed, Katherine DeSchryver, Baljit Singh, William J. Gradishar, Edith A. Perez, Silvana Martino, Marc L. Citron, Larry Norton, Eric P. Winer, Clifford A. Hudis, Lisa A. Carey, Philip S. Bernard, Torsten O. Nielsen, Charles M. Perou, Matthew J. Ellis, William T. Barry - npj Breast Cancer 2016 cited by 114

  14. A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen

    Authors: Stephen Chia, Vivien Bramwell, Dongsheng Tu, Lois E. Shepherd, Shan Jiang, Tammi L. Vickery, Elaine R. Mardis, Samuel Leung, Karen Ung, Kathleen I. Pritchard, Joel S. Parker, Philip S. Bernard, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen - Clinical Cancer Research 2012 cited by 310

  15. The molecular portraits of breast tumors are conserved across microarray platforms

    Authors: Maria Tretiakova, Matthew G. Ewend, Michael Mullins, Chad Livasy, Heidi J. Hansen, Mary C. Mone, Rita Nanda, Joel S. Parker, Edward Nelson, Lynn G. Dressler, J. S. Marron, Evangeline Reynolds, Cheng Fan, Charles M. Perou, Alejandra Ruiz Orrico, Laurent Perreard, Junyuan Wu, Philip S. Bernard, John F. Quackenbush, Yudong Liu, Zhiyuan Hu, Lynda Sawyer, Andrew B. Nobel, Daniel Oh, Juan Palazzo, Matthew J. Ellis, Xiaping He, Lisa A. Carey, Bahjat F. Qaqish, Olufunmilayo I. Olopade, Donna Dreher - BMC Genomics 2006 cited by 1,470

  16. Membrane proteins significantly restrict exosome mobility

    Authors: Mikhail Skliar, Vasiliy S. Chernyshev, David M. Belnap, German V. Sergey, Samer M. Al-Hakami, Philip S. Bernard, Inge J. Stijleman, Rakesh Rachamadugu - Biochemical and Biophysical Research Communications 2018 cited by 91

  17. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

    Authors: Matthew D. Wilkerson, Xiaoying Yin, Katherine A. Hoadley, Yufeng Liu, Michele C. Hayward, Christopher R. Cabanski, Kenneth L. Muldrew, C. Ryan Miller, Scott H. Randell, Mark A. Socinski, Alden M. Parsons, William K. Funkhouser, Carrie B. Lee, Patrick J. Roberts, Leigh B. Thorne, Philip S. Bernard, Charles M. Perou, D. Neil Hayes - Clinical Cancer Research 2010 cited by 295

  18. A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer

    Authors: Rachel L. Stewart, Katherine L. Updike, Rachel E. Factor, N. Lynn Henry, Kenneth M. Boucher, Philip S. Bernard, Katherine E. Varley - Cancer Research 2019 cited by 48

  19. Real-Time PCR Technology for Cancer Diagnostics

    Authors: Philip S. Bernard, Carl T. Wittwer - Clinical Chemistry 2002 cited by 278

  20. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake

    Authors: Candice C. Askwith, David Eide, Anthony Van Ho, Philip S. Bernard, Liangtao Li, Sandra R. Davis-Kaplan, David M. Sipe, Jerry Kaplan - Cell 1994 cited by 675

  21. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen

    Authors: Aleix Prat, Joel S. Parker, Cheng Fan, Maggie C.U. Cheang, Lance D. Miller, Jonas Bergh, Stephen Chia, Philip S. Bernard, Torsten O. Nielsen, Matthew J. Ellis, Lisa A. Carey, Charles M. Perou - Annals of Oncology 2012 cited by 141

  22. Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor Characteristics

    Authors: Carol Sweeney, Philip S. Bernard, Rachel E. Factor, Marilyn L. Kwan, Laurel A. Habel, Charles P. Quesenberry, Kaylynn Shakespear, Erin Weltzien, Inge J. Stijleman, Carole Davis, Mark Ebbert, Adrienne Castillo, Lawrence H. Kushi, Bette J. Caan - Cancer Epidemiology Biomarkers & Prevention 2014 cited by 127

  23. Molecular portraits and the family tree of cancer

    Authors: Christine H. Chung, Philip S. Bernard, Charles M. Perou - Nature Genetics 2002 cited by 265

  24. A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

    Authors: X. Cynthia, Matthew J. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-Rong Cai, Christine E. Ryan, A. Craig Lockhart, Michael Naughton, Timothy Pluard, Christiana Brenin, Joel Picus, Allison Creekmore, Tibu Mwandoro, Erin Yarde, Jerry P. Reed, Mark Ebbert, Philip S. Bernard, Mark A. Watson, L. Austin Doyle, Janet Dancey, Helen Piwnica‐Worms, Paula M. Fracasso - Breast Cancer Research and Treatment 2012 cited by 108